Filtered By:
Source: Stroke
Condition: Atrial Fibrillation

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 257 results found since Jan 2013.

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Clinical Sciences
Conclusions— Among patients with atrial fibrillation treated with anticoagulation, the risk of ICH was higher among Asians, blacks, the elderly, and in those with previous stroke or transient ischemic attack, increased diastolic blood pressure, and reduced platelet count or serum albumin at baseline. The risk of ICH was significantly lower in patients with heart failure and in those who were randomized to rivaroxaban instead of warfarin. The external validity of these findings requires testing in other atrial fibrillation populations.
Source: Stroke - April 28, 2014 Category: Neurology Authors: Hankey, G. J., Stevens, S. R., Piccini, J. P., Lokhnygina, Y., Mahaffey, K. W., Halperin, J. L., Patel, M. R., Breithardt, G., Singer, D. E., Becker, R. C., Berkowitz, S. D., Paolini, J. F., Nessel, C. C., Hacke, W., Fox, K. A. A., Califf, R. M., on behal Tags: Acute Cerebral Hemorrhage, Anticoagulants Clinical Sciences Source Type: research

Predictive Value of Newly Detected Atrial Fibrillation Paroxysms in Patients With Acute Ischemic Stroke, for Atrial Fibrillation After 90 Days Brief Reports
Conclusions— AF detection through any means immediately after stroke holds strong PPV for confirmation after 90 days, justifying treatment decisions on early monitoring alone. However, failure to identify AF through early monitoring has only modest NPV even after 7 days of monitoring; repeated investigation is desirable.
Source: Stroke - June 23, 2014 Category: Neurology Authors: Higgins, P., Dawson, J., MacFarlane, P. W., McArthur, K., Langhorne, P., Lees, K. R. Tags: Secondary prevention, Electrocardiology, Arrhythmias, clinical electrophysiology, drugs Brief Reports Source Type: research

Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure Clinical Sciences
Conclusion— Among HF patients in ACTIVE, neither the presence of LVSD or degree of symptom severity influenced risk of embolic events.
Source: Stroke - February 23, 2015 Category: Neurology Authors: Sandhu, R. K., Hohnloser, S. H., Pfeffer, M. A., Yuan, F., Hart, R. G., Yusuf, S., Connolly, S. J., McAlister, F. A., Healey, J. S. Tags: Congestive, Arrhythmias, clinical electrophysiology, drugs, Embolic stroke Clinical Sciences Source Type: research

Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial Clinical Sciences
Conclusions— The risk of cardiovascular death, stroke, or systemic embolism is higher in anticoagulated patients with permanent AF than in those with nonpermanent AF, regardless of preexisting heart failure.
Source: Stroke - August 24, 2015 Category: Neurology Authors: Senoo, K., Lip, G. Y. H., Lane, D. A., Buller, H. R., Kotecha, D. Tags: Thrombosis risk factors Clinical Sciences Source Type: research

Stroke Literature Synopses: Clinical Science Stroke Literature Synopses: Clinical Science
Source: Stroke - October 26, 2015 Category: Neurology Authors: Lin, M. P., Towfighi, A. Tags: Atrial Fibrillation, Epidemiology, Ischemic Stroke, Transient Ischemic Attack (TIA) Stroke Literature Synopses: Clinical Science Source Type: research

Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation? Controversies in Stroke
Source: Stroke - February 22, 2016 Category: Neurology Authors: Diener, H.-C., Selim, M. H., Molina, C. A., Greenberg, S. M. Tags: Atrial Fibrillation, Intracranial Hemorrhage, Ischemic Stroke Controversies in Stroke Source Type: research

Stroke Literature Synopses: Clinical Science Stroke Literature Synopses: Clinical Science
Source: Stroke - April 24, 2016 Category: Neurology Authors: Lin, M. P., Towfighi, A. Tags: Atrial Fibrillation, Ischemic Stroke Stroke Literature Synopses: Clinical Science Source Type: research

Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events Clinical Sciences
Conclusions— Prothrombotic blood alterations could be involved in the LAA thrombus formation in patients without documented atrial fibrillation and are associated with increased risk of stroke or transient ischemic attack during follow-up.
Source: Stroke - June 26, 2016 Category: Neurology Authors: Meus, R., Son, M., Sobczyk, D., Undas, A. Tags: Ischemic Stroke Clinical Sciences Source Type: research

Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Clinical Sciences
Background and Purpose—We sought to determine the risk of stroke/thromboembolism and bleeding associated with reduced renal function in patients with atrial fibrillation and the risk of stroke and bleeding associated with warfarin treatment in specific estimated glomerular filtration rate (eGFR) groups.Methods—We conducted a register-based cohort study and included patients discharged with nonvalvular atrial fibrillation from 1997 to 2011 with available eGFR.Results—A total of 17 349 patients were identified with eGFR available at baseline. All levels of lower eGFR were associated with higher risk of stroke/thrombo...
Source: Stroke - October 23, 2016 Category: Neurology Authors: Bonde, A. N., Lip, G. Y. H., Kamper, A.–L., Fosbol, E. L., Staerk, L., Carlson, N., Torp–Pedersen, C., Gislason, G., Olesen, J. B. Tags: Atrial Fibrillation Original Contributions Source Type: research

Stroke Literature Synopses: Clinical Science Stroke Literature Synopses: Clinical Science
Source: Stroke - December 22, 2016 Category: Neurology Authors: Michelle P. Lin, Amytis Towfighi Tags: Atrial Fibrillation, Genetics, Cerebrovascular Disease/Stroke Stroke Literature Synopses: Clinical Science Source Type: research

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation Clinical Sciences
Conclusions—Dabigatran was associated with a superior benefit/risk ratio than warfarin and anticoagulation discontinuation in the treatment of atrial fibrillation patients who have survived a major bleed.
Source: Stroke - December 22, 2016 Category: Neurology Authors: Inmaculada Hernandez, Yuting Zhang, Maria M. Brooks, Paul K.L. Chin, Samir Saba Tags: Atrial Fibrillation, Quality and Outcomes, Intracranial Hemorrhage, Ischemic Stroke Original Contributions Source Type: research

Stroke Patients With Suspected Atrial Fibrillation Should Be Started on Anticoagulation Pending the Results of Long-Term Cardiac Monitoring Controversies in Stroke
Source: Stroke - December 24, 2012 Category: Neurology Authors: Diener, H.-C. Tags: Secondary prevention Controversies in Stroke Source Type: research

"If It Looks Like a Duck, Walks Like a Duck, and Quacks Like a Duck... It Must Be a Duck": Anticoagulation in Stroke Patients With Suspected Atrial Fibrillation Controversies In Stroke
Source: Stroke - December 24, 2012 Category: Neurology Authors: Molina, C. A., Selim, M. Tags: Anticoagulants Controversies In Stroke Source Type: research

Letter by Diomedi et al Regarding Article "Continuous Stroke Unit Electrocardiographic Monitoring Versus 24-Hour Holter Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After Stroke" Letters to the Editor
Source: Stroke - January 18, 2013 Category: Neurology Authors: Diomedi, M., Di Legge, S., Sallustio, F. Tags: Electrocardiology, Echocardiography, Acute Cerebral Infarction, Arrhythmias, clinical electrophysiology, drugs, Embolic stroke Letters to the Editor Source Type: research

Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study) Clinical Sciences
Conclusions— We found no evidence that anticoagulation confers clinically important protection over aspirin against cognitive decline as measured by the Mini-Mental State Examination in atrial fibrillation in the first 33 months of treatment other than that provided by preventing clinical stroke. Clinical Trial Registration— URL: http://www.controlled-trials.com. Unique identifier: ISRCTN89345269.
Source: Stroke - April 28, 2014 Category: Neurology Authors: Mavaddat, N., Roalfe, A., Fletcher, K., Lip, G. Y. H., Hobbs, F. D. R., Fitzmaurice, D., Mant, J. Tags: Arrhythmias, clinical electrophysiology, drugs, Primary and Secondary Stroke Prevention, Anticoagulants Clinical Sciences Source Type: research